Tectonic Therapeutic, Inc.
TECX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001681087
In the last 90 days, Tectonic Therapeutic, Inc. insiders filed 0 open-market purchases and 2 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $479.9M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tectonic Therapeutic, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +5 vs. Q2 2021
- Shares held
- 29.8M
- −2.54M (−7.9%) vs. Q2 2021
- Total value
- $166.5M
- −$121.2M (−42.1%) vs. Q2 2021
- New holders
- 21
- 34 more added
- Sold out
- 16
- 27 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TECX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $479.9M |
| Q1 2026 | 111 | $426.8M |
| Q4 2025 | 105 | $288.1M |
| Q3 2025 | 99 | $189.9M |
| Q2 2025 | 82 | $240.7M |
| Q1 2025 | 78 | $198.8M |
| Q4 2024 | 70 | $354.9M |
| Q3 2024 | 53 | $217.4M |
| Q2 2024 | 40 | $88.1M |
| Q1 2024 | 47 | $35.2M |
| Q4 2023 | 45 | $32.2M |
| Q3 2023 | 48 | $39.9M |
| Q2 2023 | 41 | $18.9M |
| Q1 2023 | 48 | $22.8M |
| Q4 2022 | 45 | $14.8M |
| Q3 2022 | 54 | $15.7M |
| Q2 2022 | 64 | $23.8M |
| Q1 2022 | 81 | $38.8M |
| Q4 2021 | 94 | $134.9M |
| Q3 2021 | 101 | $166.5M |
| Q2 2021 | 97 | $287.7M |
| Q1 2021 | 99 | $423.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tectonic Therapeutic, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 4,609,602 | $25.7M | 0.00% | −278,714−5.7% | Reduced |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −689,002−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −325,891−100.0% | Sold out |
| Burrage Capital Management LLC | 0 | $0 | 0.00% | −244,920−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −109,460−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −108,943−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −39,849−100.0% | Sold out |
| Penn Mutual Asset Management, LLC | 0 | $0 | 0.00% | −26,114−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −24,334−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −22,030−100.0% | Sold out |
| Strategic Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −19,100−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,061−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −188−100.0% | Sold out |
| Enterprise Financial Services Corp | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |